Cancer Diagnostics Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2019 - 2027
- Transparency Market Research
- October 2020
- Cancer Diagnostics
- 124 pages
Global Cancer Diagnostics Market - Scope of Report
TMR’s report on the global cancer diagnostics market studies past as well as current growth trends and opportunities to gain valuable insights of these indicators of the market during the forecast period from 2019 to 2027. The report provides revenue of the global cancer diagnostics market for the period 2017–2027, considering 2018 as the base year and 2027 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the global cancer diagnostics market during the forecast period.
The report has been prepared after an extensive primary and secondary research. Primary research involved bulk of research efforts, wherein analysts carried out interviews with industry leaders and opinion makers. Extensive secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the global cancer diagnostics market.
Secondary research also included Internet sources, statistical data from government agencies, websites, company presentations, sales data, and trade associations. Analysts have employed a combination of top-down and bottom-up approaches to study various phenomenon in the global cancer diagnostics market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Furthermore, the report sheds light on the changing competitive dynamics in the global cancer diagnostics market. These indices serve as valuable tools for existing market players as well as for entities interested in entering the global cancer diagnostics market.
The report delves into the competitive landscape of the global cancer diagnostics market. Key players operating in the global cancer diagnostics market have been identified, and each one of these has been profiled for distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players in the global cancer diagnostics market that have been profiled in this report.
Key Questions Answered in Global Cancer Diagnostics Market Report
- What is the scope of growth of product companies in the global cancer diagnostics market?
- What will be the Y-o-Y growth of the global cancer diagnostics market between 2019 and 2027?
- What is the influence of changing trends in technologies on the global cancer diagnostics market?
- Will North America continue to be the most profitable market for cancer diagnostics providers?
- Which factors are anticipated to hamper the growth of the global cancer diagnostics market during the forecast period?
- Which are the leading companies in the global cancer diagnostics market?
A unique research methodology has been utilized by TMR to conduct comprehensive research on the growth of the global cancer diagnostics market and arrive at conclusions on its growth prospects. This research methodology is a combination of primary and secondary research, which helps analysts warrant the accuracy and reliability of the drawn conclusions.
Secondary methods referred to by analysts during the production of the global cancer diagnostics market report include statistics from company annual reports, SEC filings, company websites, investor presentations, regulatory databases, government publications, and industry white papers. Analysts have also interviewed senior managers, product portfolio managers, CEOs, VPs, and market intelligence managers, who contributed to the production of TMR’s study on the cancer diagnostics market as primary methods.
These primary and secondary methods have provided exclusive information during interviews, which serves as a validation from the cancer diagnostics market leaders. Access to an extensive internal repository and external proprietary databases enabled this report to address specific details and questions about the global cancer diagnostics market with accuracy. The study also uses the top-down approach to assess the revenues for each segment and the bottom-up approach to counter-validate them. This has helped in reaching TMR’s estimates on future prospects of the global cancer diagnostics market more reliably and accurately.
Regional Segmentation of Cancer Diagnostics Market
- North America
- Rest of Europe
- Asia Pacific
- Australia & New Zealand
- Rest of Asia Pacific
- Latin America
- Rest of Latin America
- Middle East & Africa
- GCC Countries
- South Africa
- Rest of Middle East & Africa
Global Cancer Diagnostics Market – Segmentation
- Bone Marrow Biopsy
- Needle Biopsy
- Endoscopic Biopsy
- MRI Scan
- PET Scan
- CT Scan
- Tumor Biomarker Tests
- PSA Tests
- CTC Tests
- AFP Tests
- CA 19-9
- CA 125
- Blood Cancer
- Breast Cancer
- Colorectal Cancer
- Kidney Cancer
- Liver Cancer
- Lung Cancer
- Ovarian Cancer
- Pancreatic Cancer
- Prostate Cancer
- North America
- Asia Pacific
- Latin America
- Middle East & Africa
Have query on this report?Make an Enquiry
Table of Content
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objective
1.4. Research Highlight
2. Assumptions and Research Methodology
3. Executive Summary: Global Cancer Diagnostics Market
4. Market Overview
4.1.1. Type Definition
4.1.2. Industry Evolution / Development
4.3. Market Dynamic
4.4. Global Cancer Diagnostics Market Analysis and Forecast, 2017–2027
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Regulatory Scenario and Reimbursement
5.2. Cancer Epidemiology
5.3. List of active market participants (suppliers/distributors/manufacturers/vendors)
6. Global Cancer Diagnostics Market Analysis and Forecast, by Method
6.1. Introduction & Definition
6.1.1. Key Findings / Development
6.2. Global Cancer Diagnostics Market Value Forecast, by Method, 2017–2027
22.214.171.124. Bone Marrow Biopsy
126.96.36.199. Needle Biopsy
188.8.131.52. Endoscopic Biopsy
184.108.40.206. MRI Scan
220.127.116.11. PET Scan
18.104.22.168. CT Scan
6.2.4. Tumor Biomarker Test
22.214.171.124. PSA Test
126.96.36.199. CTC Test
188.8.131.52. AFP Test
184.108.40.206. CA 19-9
220.127.116.11. CA 125
6.3. Global Cancer Diagnostics Market Attractiveness, by Method
7. Global Cancer Diagnostics Market Analysis and Forecast, by Application
7.1. Introduction & Definition
7.1.1. Key Findings / Development
7.2. Global Cancer Diagnostics Market Value Forecast, by Application, 2017–2027
7.2.1. Blood Cancer
7.2.2. Breast Cancer
7.2.3. Colorectal Cancer
7.2.4. Kidney Cancer
7.2.5. Liver Cancer
7.2.6. Lung Cancer
7.2.7. Ovarian Cancer
7.2.8. Pancreatic Cancer
7.2.9. Prostate Cancer
7.3. Global Cancer Diagnostics Market Attractiveness, by Application
8. Global Cancer Diagnostics Market Analysis and Forecast, by Region
8.1. Key Finding
8.2. Global Cancer Diagnostics Market Value Forecast, by Region
8.2.1. North America
8.2.3. Asia Pacific
8.2.4. Latin America
8.2.5. Middle East & Africa
8.3. North America Cancer Diagnostics Market Attractiveness, by Region
List of Table
Table 1 List of Abbreviation
Table 2 Market Snapshot: Global Cancer Diagnostics Market
Table 3 List of Cancer Risk Factors
Table 4 Estimated Incidence, 1 year, 2 years and 5 years survival
Table 5 Breast Cancer Companion Diagnostics (CDx), Manufacturers and Target Drugs
Table 6 Lung Cancer Companion Diagnostics (CDx), Manufacturers and Target Drugs
Table 7 Colorectal Cancer Companion Diagnostics (CDx), Manufacturers and Target Drugs
Table 8 Summary of Type of Diagnostics Test in the U.S.
Table 9 Event Impact Analysis: Global Cancer Diagnostics Market, 2017-2027
Table 10 Global Cancer Diagnostics Market Revenue, by Method, 2017-2027 (USD) Million
Table 11 Global Cancer Diagnostics Market Revenue, by Application, 2017-2027 (USD) Million
Table 12 Global Cancer Diagnostics Market Revenue, by Geography, 2017-2027 (USD) Million
The team was the biggest help to us. Not only were we provided with customized solutions but also we were guided through the most complicated situations. The information was on-point yet comprehensive. The experience was absolutely satisfying and helped us turn many challenges into opportunities.
Ours is a startup with a unique set of challenges and we were therefore hesitant but the team totally put us at ease with their knowledge and expertise. Our business and its challenges were understood perfectly and help was extended accordingly. The tailor made approach really helped us gain the most informative insights.
The report repository is absolutely impressive –updated and exhaustive in terms of markets covered and information provides. Besides, with the support extended to us by the team, we could reduce costs as well as move to sustainable growth. This really helped us tap into new opportunities. Happy to have gone ahead with ResearchMos.us.
We have had a long term engagement with ResearchMoz.us and never have we felt that the work done and help extended were below flawless. The report repository is one of the best one can hope to tap into. Recently, our partner businesses opted for consultancy services and they are all thrilled with the outcome.
Insights from reports helped us improve our profit margins significantly. Most of the knowledge we needed on the market were provided to us on a granular basis. From trends, and drivers to competitive analysis, the information was not just crisp but also insightful. That helped us chart a robust growth strategy and as of now we are happy to state that we are reaping big benefits.
More from Cancer Diagnostics
Cancer DiagnosticsGlobal Cancer Diagnostics Industry 2017, Trends and Forecast Report
Cancer DiagnosticsGlobal Kidney Cancer Diagnostics and Therapeutics Sales Market Report 2017
Cancer DiagnosticsGlobal Head Cancer Diagnostics Market Research Report 2017
Pharmaceuticals and HealthcareGlobal Bionic Ears Market Professional Survey Report 2017
Pharmaceuticals and HealthcareNeuropsychiatric Disorder Cluster Drug Development Pipeline Review, 2017
Pharmaceuticals and HealthcareHepatitis Drug Development Pipeline Review, 2017